Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on notice late Monday. The move is clearly a retaliatory ...

It was put on a blacklist by the latter country. China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

(Reuters) -Shares of genetic testing company Illumina and Calvin Klein-owner PVH Corp fell on Tuesday after China placed the two companies on its "unreliable entity" list, putting them at risk of ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

China’s Ministry of Commerce on Tuesday added Illumina, a maker of DNA sequencing systems, to its unreliable entity list as trade tensions with the U.S. flared. Listing Illumina as an untrustworthy ...

Regeneron and Illumina have joined a major investment ... datasets have led to important new approaches to help prevent heart disease and restore hearing in children with certain forms of ...

RIGHT, RIGHT. SO IT’S A GOOD BALANCE BETWEEN BEING FEARFUL ABOUT YOUR HEART HEALTH AND BEING CAVALIER ABOUT YOUR HEART HEALTH. LIKE WHEN WE ARE YOUNG IN OUR 30S, WE THINK THAT NOTHING WILL.